<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="9588">Ticlopidine</z:chebi> is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with severe bone marrow suppression, typically <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Reports in the literature of isolated <z:mp ids='MP_0000334'>agranulocytosis</z:mp> are few, although they may be associated with significant morbidity and mortality </plain></SENT>
<SENT sid="2" pm="."><plain>A case is reported of an elderly woman who developed febrile <z:mp ids='MP_0000334'>agranulocytosis</z:mp> several weeks after commencing <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> but who had a favorable outcome after cessation of that drug and treatment with filgastrim </plain></SENT>
</text></document>